BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 16109430)

  • 1. Cannabinoid signalling.
    Demuth DG; Molleman A
    Life Sci; 2006 Jan; 78(6):549-63. PubMed ID: 16109430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids.
    McAllister SD; Glass M
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):161-71. PubMed ID: 12052033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid signalling in the enteric nervous system.
    Galligan JJ
    Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
    Ramer R; Hinz B
    J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction of the CB1 cannabinoid receptor.
    Turu G; Hunyady L
    J Mol Endocrinol; 2010 Feb; 44(2):75-85. PubMed ID: 19620237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptors: G-protein-mediated signal transduction mechanisms.
    Childers SR; Pacheco MA; Bennett BA; Edwards TA; Hampson RE; Mu J; Deadwyler SA
    Biochem Soc Symp; 1993; 59():27-50. PubMed ID: 8192687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
    Rao GK; Kaminski NE
    J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and molecular characterization of a dorsal root ganglion cell line expressing cannabinoid CB(1) and CB(2) receptors.
    Fan Y; Hooker BA; Garrison TR; El-Kouhen OF; Idler KB; Holley-Shanks RR; Meyer MD; Yao BB
    Eur J Pharmacol; 2011 Jun; 659(2-3):161-8. PubMed ID: 21458448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cannabinoid system and immune modulation.
    Klein TW; Newton C; Larsen K; Lu L; Perkins I; Nong L; Friedman H
    J Leukoc Biol; 2003 Oct; 74(4):486-96. PubMed ID: 12960289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
    Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids and ceramide: two lipids acting hand-by-hand.
    Velasco G; Galve-Roperh I; Sánchez C; Blázquez C; Haro A; Guzmán M
    Life Sci; 2005 Aug; 77(14):1723-31. PubMed ID: 15958274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids.
    Oz M
    Pharmacol Ther; 2006 Jul; 111(1):114-44. PubMed ID: 16584786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
    Yao BB; Hsieh G; Daza AV; Fan Y; Grayson GK; Garrison TR; El Kouhen O; Hooker BA; Pai M; Wensink EJ; Salyers AK; Chandran P; Zhu CZ; Zhong C; Ryther K; Gallagher ME; Chin CL; Tovcimak AE; Hradil VP; Fox GB; Dart MJ; Honore P; Meyer MD
    J Pharmacol Exp Ther; 2009 Jan; 328(1):141-51. PubMed ID: 18931146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of functionally active cannabinoid receptor CB1 in the human prostate gland.
    Ruiz-Llorente L; Sánchez MG; Carmena MJ; Prieto JC; Sánchez-Chapado M; Izquierdo A; Díaz-Laviada I
    Prostate; 2003 Feb; 54(2):95-102. PubMed ID: 12497582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor.
    Jarrahian A; Watts VJ; Barker EL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):880-6. PubMed ID: 14634050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid system and gut-brain signalling.
    Storr MA; Sharkey KA
    Curr Opin Pharmacol; 2007 Dec; 7(6):575-82. PubMed ID: 17904903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction activated by cannabinoid receptors.
    Díaz-Laviada I; Ruiz-Llorente L
    Mini Rev Med Chem; 2005 Jul; 5(7):619-30. PubMed ID: 16026308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors.
    Merighi S; Simioni C; Gessi S; Varani K; Borea PA
    Biochem Pharmacol; 2010 Feb; 79(3):471-7. PubMed ID: 19766600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of type 1 and type 2 cannabinoid receptors along the neuroimmune axis.
    Oddi S; Spagnuolo P; Bari M; D'Agostino A; Maccarrone M
    Int Rev Neurobiol; 2007; 82():327-37. PubMed ID: 17678969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.